R Tony Tripeny Buys 900 Shares of Mesa Laboratories (NASDAQ:MLAB) Stock

Mesa Laboratories, Inc. (NASDAQ:MLAB) Director R Tony Tripeny purchased 900 shares of the business’s stock in a transaction that occurred on Thursday, August 13th. The stock was bought at an average cost of $113.69 per share, for a total transaction of $102,321.00. Following the completion of the acquisition, the director directly owned 6,298 shares in the company, valued at $716,019.62. The trade was a 16.67% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Mesa Laboratories Trading Up 0.3%

Shares of MLAB stock opened at $107.94 on Wednesday. The company has a 50 day moving average of $100.60 and a 200-day moving average of $96.46. Mesa Laboratories, Inc. has a 12-month low of $58.83 and a 12-month high of $115.52. The firm has a market cap of $604.46 million, a P/E ratio of 128.50 and a beta of 0.92. The company has a quick ratio of 1.32, a current ratio of 1.79 and a debt-to-equity ratio of 0.73.

Mesa Laboratories (NASDAQ:MLAB) last released its earnings results on Monday, August 10th. The medical instruments supplier reported $2.68 earnings per share (EPS) for the quarter. The business had revenue of $60.14 million during the quarter. Mesa Laboratories had a return on equity of 22.72% and a net margin of 1.92%.

Mesa Laboratories Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Monday, August 31st will be issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Monday, August 31st. Mesa Laboratories’s payout ratio is presently 76.19%.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of MLAB. Ranger Investment Management L.P. purchased a new position in shares of Mesa Laboratories during the second quarter valued at approximately $17,321,000. Diamond Hill Capital Management LLC Investment Advisor purchased a new position in shares of Mesa Laboratories in the second quarter worth $15,507,000. Boston Partners boosted its holdings in shares of Mesa Laboratories by 2,009.5% during the 3rd quarter. Boston Partners now owns 114,357 shares of the medical instruments supplier’s stock valued at $7,664,000 after acquiring an additional 108,936 shares during the last quarter. Millennium Management LLC lifted its position in Mesa Laboratories by 131.9% during the third quarter. Millennium Management LLC now owns 133,817 shares of the medical instruments supplier’s stock valued at $8,967,000 after purchasing an additional 76,107 shares during the period. Finally, Wasatch Advisors LP lifted its holdings in shares of Mesa Laboratories by 125.8% during the 2nd quarter. Wasatch Advisors LP now owns 115,668 shares of the medical instruments supplier’s stock valued at $11,515,000 after buying an additional 64,435 shares during the period. 90.60% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the company. Weiss Ratings upgraded Mesa Laboratories from a “sell (d)” rating to a “hold (c-)” rating in a research note on Tuesday, August 11th. Wall Street Zen cut shares of Mesa Laboratories from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Finally, Wells Fargo & Company lifted their price target on Mesa Laboratories from $94.00 to $110.00 and gave the stock an “equal weight” rating in a research note on Friday, August 14th. Three investment analysts have rated the stock with a Hold rating, According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $110.00.

About Mesa Laboratories

Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.